pindolol has been researched along with Parkinson Disease in 4 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoenen, J | 1 |
| Delwaide, PJ | 1 |
| Waeber, C | 1 |
| Rigo, M | 1 |
| Chinaglia, G | 1 |
| Probst, A | 1 |
| Palacios, JM | 1 |
| Broussolle, E | 1 |
| Borson, F | 1 |
| Gonzalez de Suso, JM | 1 |
| Chayvialle, JA | 1 |
| Beylot, M | 1 |
| Chazot, G | 1 |
| von Egidy, H | 1 |
1 trial available for pindolol and Parkinson Disease
| Article | Year |
|---|---|
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
3 other studies available for pindolol and Parkinson Disease
| Article | Year |
|---|---|
Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Autoradiography; Basal Ganglia; Binding Sites; Binding, Competitive; Female | 1991 |
[Increase of energy expenditure in Parkinson's disease].
Topics: Adult; Aged; Autonomic Nervous System; Calorimetry; Energy Metabolism; Female; Humans; Hypoglycemia; | 1991 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |